Adaptive Biotechnologies Names New CFO Preserves Strong Capital Position

Adaptive Biotechnologies Corporation ADPT announced Tuesday, April 3, that after a strategic review, the company will operate two businesses — Minimal Residual Disease (MRD) and Immune Medicine (IM) — internally. The company will also restructure each business with dedicated resources and separate…#mrd #immunemedicine #adaptive #tychopeterson #cfo #kylepiskel #williamblair #adpt
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Biotechnology | Health